Novel Pseudomonas aeruginosa Strains Co-Harbouring bla_NDM-1 Metallo β-Lactamase and mcr-1 Isolated from Immunocompromised Paediatric Patients

References

• Winfried K, Jan R, Hartmut B, et al.; Hospital Infection Surveillance System for Patients With Hematologic/Oncologic Malignancies Study Group (ONKO-KISS). Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: results from a multicentric surveillance cohort study. Transpl Infect Dis. 2019;21:e13186. doi:10.1111/tid.13186
   Web of Science ®Google Scholar
• Reynolds D, Kollef M. The epidemiology and pathogenesis and treatment of pseudomonas aeruginosa infections: an update. Drugs. 2021;81(18):2117–2131. doi:10.1007/s40265-021-01635-6
   PubMed Web of Science ®Google Scholar
• Tofas P, Samarkos M, Piperaki ET, et al. Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome. Diagn Microbiol Infect Dis. 2017;88(4):335–341. doi:10.1016/j.diagmicrobio.2017.05.003
   Web of Science ®Google Scholar
• Available from: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed June 1, 2022.
   Google Scholar
• Bottery MJ, Pitchford JW, Friman VP. Ecology and evolution of antimicrobial resistance in bacterial communities. ISME J. 2021;15(4):939–948. doi:10.1038/s41396-020-00832-7
   Web of Science ®Google Scholar
• Aloush V, Navon-Venezia S, Seigman-Igra Y, Cabili S, Carmeli Y. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother. 2006;50(1):43–48. doi:10.1128/AAC.50.1.43-48.2006
   PubMed Web of Science ®Google Scholar
• Horcajada JP, Montero M, Oliver A, et al. Epidemiology and treatment of multidrug-resistant and extensively drug-resistant pseudomonas aeruginosa infections. Clin Microbiol Rev. 2019;32(4):e00031–e00019. doi:10.1128/CMR.00031-19
   PubMed Web of Science ®Google Scholar
• Mekonnen H, Seid A, Molla Fenta G, Gebrecherkos T. Antimicrobial resistance profiles and associated factors of Acinetobacter and Pseudomonas aeruginosa nosocomial infection among patients admitted at Dessie comprehensive specialized Hospital, North-East Ethiopia. A cross-sectional study. PLoS One. 2021;16(11):e0257272. doi:10.1371/journal.pone.0257272
   Web of Science ®Google Scholar
• Sandip P, Jiang M, Wen F. Molecular characterization of co-existence of MCR-1 and NDM-1 in extended-spectrum β-lactamase-producing Escherichia coli ST648 isolated from a colonized patient in China. Jundishapur J Microbiol. 2019;12(7):e91272.
   Web of Science ®Google Scholar
• Patil S, Liu X, Chen H, Francisco NM, Wen F, Chen Y. Genetic characterization of colistin-resistant Salmonella enterica ST34 Co-harbouring plasmid-Borne mcr-1, blaCTX-M-15 and blaKPC-2 recovered from a paediatric patient in Shenzhen, China. Infect Drug Resist. 2022;15:757–763. doi:10.2147/IDR.S349585
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS): whole-genome sequencing for surveillance of antimicrobial resistance. Geneva: World Health Organization; 2020.
   Google Scholar
• World Health Organization. Global antimicrobial resistance surveillance system (GLASS) report. Geneva: World Health Organization; 2019.
   Google Scholar
• Hendriksen RS, Bortolaia V, Tate H, Tyson GH, Aarestrup FM, McDermott PF. Using genomics to track global antimicrobial resistance. Front Public Health. 2019;7:242. doi:10.3389/fpubh.2019.00242
   PubMed Web of Science ®Google Scholar
• Picão R, Andrade S, Nicoletti A, et al. Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol. 2008;46:2028–2037. doi:10.1128/JCM.00818-07
   PubMed Web of Science ®Google Scholar
• Patel JB, Cockerill FR, Bradford PA. M100-S25 performance standards for antimicrobial susceptibility testing; Twenty-fifth informational supplement; 2015.
   Google Scholar
• Matuschek E, Åhman J, Webster C, Kahlmeter G. Antimicrobial susceptibility testing of colistin - evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clin Microbiol Infect. 2018;24(8):865–870. doi:10.1016/j.cmi.2017.11.020
   Google Scholar
• Patil S, Chen H, Zhang X, Lian M, Ren PG, Wen F. Antimicrobial resistance and resistance determinant insights into multi-drug resistant gram-negative bacteria isolates from paediatric patients in China. Infect Drug Resist. 2019;12:3625–3634. doi:10.2147/IDR.S223736
   PubMed Web of Science ®Google Scholar
• Zhuoren L, Wenjuan Y, Zhangqi S, Yang W, Jianzhong S, Timothy W. Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9. J Antimicrob Chemother. 2020;75(11):3087–3095. doi:10.1093/jac/dkaa205
   Web of Science ®Google Scholar
• Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods. 2005;63(3):219–228. doi:10.1016/j.mimet.2005.03.018
   PubMed Web of Science ®Google Scholar
• Alvarado A, Garcillán-Barcia MP, de la Cruz F. A degenerate primer MOB typing (DPMT) method to classify gamma-proteobacterial plasmids in clinical and environmental settings. PLoS One. 2012;7(7):e40438. doi:10.1371/journal.pone.0040438
   PubMed Web of Science ®Google Scholar
• Raúl R, Jennifer V, Esther V, María Á, Jaime L, Fernando C. Bacteraemia due to extensively drug-resistant Pseudomonas aeruginosa sequence type 235 high-risk clone: facing the perfect storm. Int J Antimicrob Agents. 2018;52(2):172–179. doi:10.1016/j.ijantimicag.2018.03.018
   Web of Science ®Google Scholar
• Caselli E, D’Accolti M, Soffritti I, Piffanelli M, Mazzacane S. Spread of mcr-1-driven colistin resistance on hospital surfaces, Italy. Emerg Infect Dis. 2018;24(9):1752–1753. doi:10.3201/eid2409.171386
   PubMed Web of Science ®Google Scholar
• Usai D, Donadu M, Bua A, et al. Enhancement of antimicrobial activity of pump inhibitors associating drugs. J Infect Dev Ctries. 2019;13(2):162–164. doi:10.3855/jidc.11102
   Web of Science ®Google Scholar
• Zheng P, Renee R, Bernard R, Tong-Jun L, Zhenyu C. Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv. 2019;37(1):177–192. doi:10.1016/j.biotechadv.2018.11.013
   Web of Science ®Google Scholar
• Hamed T, Sanaz D, Mohammad Reza A. Co-harboring of mcr-1 and β-lactamase genes in Pseudomonas aeruginosa by high-resolution melting curve analysis (HRMA): molecular typing of superbug strains in bloodstream infections (BSI). Infect Genet Evol. 2020;85:104518. doi:10.1016/j.meegid.2020.104518
   Web of Science ®Google Scholar
• Jovcic B, Zorica L, Vesna S, et al. Emergence of NDM-1 metallo-beta-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia. Antimicrob Agents Chemother. 2011;55(8):3929–3931. doi:10.1128/AAC.00226-11
   PubMed Web of Science ®Google Scholar
• Cecilia Q, Marcela N, JoséDi C. Current scenario of plasmid-mediated colistin resistance in Latin America. Rev Argent Microbio. 2019;51(1):93–100.
   Web of Science ®Google Scholar
• Lidia R, Alba B, Jessica B, et al. Pseudomonas aeruginosa Isolates from Spanish Children: occurrence in Faecal Samples, Antimicrobial Resistance, Virulence, and Molecular Typing. Biomed Res Int. 2018;2018:1–8.
   Web of Science ®Google Scholar
• Schwab F, Geffers C, Behnke M, Petra J. ICU mortality following ICU-acquired primary bloodstream infections according to the type of pathogen: a prospective cohort study in 937 Germany ICUs (2006–2015). PLoS One. 2018;13(3):1–13. doi:10.1371/journal.pone.0194210
   Web of Science ®Google Scholar
• Liu Z, Liu Y, Xi W, et al. Genetic features of plasmid- and chromosome-mediated mcr-1 in Escherichia coli isolates from animal organs with lesions. Front Microbiol. 2021;12:707332. doi:10.3389/fmicb.2021.707332
   Web of Science ®Google Scholar
• Michel D, Gauri G, Philip A, et al. Detection of the plasmid-mediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales. J Antimicrob Chemother. 2016;71(8):2300–2305. doi:10.1093/jac/dkw093
   Web of Science ®Google Scholar
• Michael M, Laura M, James R, et al. Dissemination of the mcr-1 colistin resistance gene. Lancet Infect Dis. 2016;16(3):289–290. doi:10.1016/S1473-3099(16)00067-0
   Google Scholar
• Gajdács M, Baráth Z, Kárpáti K, et al. No correlation between biofilm formation, virulence factors, and antibiotic resistance in Pseudomonas aeruginosa: results from a laboratory-based in vitro study. Antibiotics. 2021;10(9):1134. doi:10.3390/antibiotics
   Google Scholar